SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-014290
Filing Date
2021-11-03
Accepted
2021-11-03 16:01:13
Documents
92
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q icpt-20210930x10q.htm   iXBRL 10-Q 2586050
2 EX-31.1 icpt-20210930xex31d1.htm EX-31.1 9881
3 EX-31.2 icpt-20210930xex31d2.htm EX-31.2 9864
4 EX-32.1 icpt-20210930xex32d1.htm EX-32.1 10351
  Complete submission text file 0001558370-21-014290.txt   10097832

Data Files

Seq Description Document Type Size
5 EX-101.SCH icpt-20210930.xsd EX-101.SCH 63228
6 EX-101.CAL icpt-20210930_cal.xml EX-101.CAL 71323
7 EX-101.DEF icpt-20210930_def.xml EX-101.DEF 234182
8 EX-101.LAB icpt-20210930_lab.xml EX-101.LAB 448867
9 EX-101.PRE icpt-20210930_pre.xml EX-101.PRE 429432
10 EXTRACTED XBRL INSTANCE DOCUMENT icpt-20210930x10q_htm.xml XML 2065837
Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35668 | Film No.: 211375227
SIC: 2834 Pharmaceutical Preparations